Certified by Founder Lodge
Viking Global Investors
United States - Greenwich, Connecticut
INVESTOR
1 Disclosed Funding Rounds $401,000,000
27 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Viking Global Investors LP (“Viking”) is a global investment firm founded in 1999. We employ a fundamentals-driven investment approach to managing over $40 billion of capital across long/sho
Company | Date | Round | Raised |
---|---|---|---|
ID.me | April, 12 ,2023 | Series D | $132,000,000 |
Arctic Wolf | October, 06 ,2022 | Unknown | $401,000,000 |
Abdera Therapeutics | April, 24 ,2023 | Series B | $142,000,000 |
Ensoma | February, 06 ,2023 | Series B | $85,000,000 |
Solarea Bio | May, 09 ,2023 | Series B | $15,000,000 |
AlphaSense | June, 15 ,2022 | Series D | $225,000,000 |
Pragma Bio | March, 27 ,2023 | Unknown | $10,000,000 |
Lightmatter | June, 01 ,2023 | Series C | $154,000,000 |
Global Processing Services | January, 13 ,2022 | Unknown | $100,000,000 |
DermBiont, Inc. | October, 25 ,2023 | Series B | $35,200,000 |
ID.me | April, 12 ,2023 | Series D | $132,000,000 |
Triveni Bio | October, 27 ,2023 | Series A | $92,000,000 |
Abdera Therapeutics | April, 24 ,2023 | Series B | $142,000,000 |
HI-Bio | January, 05 ,2024 | Series B | $95,000,000 |
Solarea Bio | May, 09 ,2023 | Series B | $15,000,000 |
Valsoft Corporation | January, 22 ,2024 | Unknown | $170,000,000 |
Lightmatter | June, 01 ,2023 | Series C | $154,000,000 |
Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
DermBiont, Inc. | October, 25 ,2023 | Series B | $35,200,000 |
Antheia, Inc. | July, 23 ,2024 | Unknown | $17,000,000 |
Triveni Bio | October, 27 ,2023 | Series A | $92,000,000 |
Metsera | November, 14 ,2024 | Series B | $215,000,000 |
HI-Bio | January, 05 ,2024 | Series B | $95,000,000 |
Valsoft Corporation | January, 22 ,2024 | Unknown | $170,000,000 |
Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
Antheia, Inc. | July, 23 ,2024 | Unknown | $17,000,000 |
Metsera | November, 14 ,2024 | Series B | $215,000,000 |